Search the MBS

Vitamins - quantitation of vitamins B1, B2, B3, B6 or C  in blood, urine or other body fluid - 1 or more tests

Fee: $30.60 Benefit: 75% = $22.95 85% = $26.05

• Previous - Item 66596
• Next - Item 66606

Prostate specific antigen (PSA), quantitation of 2 or more fractions of PSA and any derived index, including, if performed, a test described in item 66656, in the follow up of a PSA result under item 66654 or 66655 that lies at:

(a) more than 2.0 ug/L but less than or equal to 5.5 ug/L for patients with a family history of prostate cancer; or

(b) more than 3.0 ug/L but less than or equal to 5.5 ug/L for patients who are at least 50 years of age but under 70 years of age; or

(c) more than 5.5 ug/L but less than or equal to 10.0 ug/L for patients who are at least 70 years of age

For any particular patient, applicable not more than once in 11 months

Fee: $37.30 Benefit: 75% = $28.00 85% = $31.75

• Previous - Item 66656
• Next - Item 66660

Detection and quantitation, if present, of free kappa and lambda light chains in serum for the diagnosis or monitoring of amyloidosis, myeloma or plasma cell dyscrasias.

Fee: $59.60 Benefit: 75% = $44.70 85% = $50.70

• Previous - Item 71198
• Next - Item 71202

Cytology of material obtained directly from a patient by fine needle aspiration of solid tissue or tissues - 1 identified site

Fee: $68.15 Benefit: 75% = $51.15 85% = $57.95

• Previous - Item 73047
• Next - Item 73051

Immunocytochemical examination of material obtained by procedures described in items 73045, 73047, 73049, 73051, 73062, 73063, 73066 and 73067 for the characterisation of a malignancy by immunofluorescence, immunoperoxidase or other labelled antibody techniques with multiple antigenic specificities per specimen - 1 to 3 antibodies except those listed in 73061

(Item is subject to rule 13)

Fee: $43.00 Benefit: 75% = $32.25 85% = $36.55

• Previous - Item 73051
• Next - Item 73060

Immunocytochemical examination of material obtained by procedures described in items 73045, 73047, 73049, 73051, 73062, 73063, 73066 and 73067  for the characterisation of a malignancy by immunofluorescence, immunoperoxidase or other labelled antibody techniques with multiple antigenic specificities per specimen - 4 to 6  antibodies

(Item is subject to rule 13)

Fee: $57.35 Benefit: 75% = $43.05 85% = $48.75

• Previous - Item 73059
• Next - Item 73061

Immunocytochemical examination of material obtained by procedures described in items 73045, 73047, 73049, 73051, 73062, 73063, 73066 and 73067 for the characterisation of a malignancy by immunofluorescence, immunoperoxidase or other labelled antibody techniques with multiple antigenic specificities per specimen - 1 to 3 of the following antibodies - oestrogen, progesterone and c-erb-B2 (HER2)

(Item is subject to rule 13)

Fee: $51.20 Benefit: 75% = $38.40 85% = $43.55

• Previous - Item 73060
• Next - Item 73062

Detection of mutation of the FMR1 gene where:

(a) the patient exhibits intellectual disability, ataxia, neurodegeneration, or premature ovarian failure consistent with an FMRI mutation; or

(b) the patient has a relative with a FMR1 mutation

1 or more tests

Fee: $101.30 Benefit: 75% = $76.00 85% = $86.15

(See para PN.0.23, PN.7.16 of explanatory notes to this Category)

• Previous - Item 73299
• Next - Item 73301

Characterisation of gene rearrangement or the identification of mutations within a known gene rearrangement, in the diagnosis and monitoring of patients with laboratory evidence of:

(a)    acute myeloid leukaemia; or

(b)    acute promyelocytic leukaemia; or

(c)    acute lymphoid leukaemia; or

(d)    chronic myeloid leukaemia;

Fee: $230.95 Benefit: 75% = $173.25 85% = $196.35

• Previous - Item 73312
• Next - Item 73315

A test described in item 73314, if rendered by a receiving APP - 1 or more tests

(Item is subject to rule 18)

Fee: $230.95 Benefit: 75% = $173.25 85% = $196.35

• Previous - Item 73314
• Next - Item 73317